Sean Bohen
Net worth: 2 M $ as of 30/09/2026
Net worth: 2 M $ as of 30/09/2026
Dr. Sean P.
Bohen is a President, Chief Executive Officer & Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Gyroscope Therapeutics Ltd., Olema Pharmaceuticals, Inc. and AltruBio, Inc. Dr. Bohen was previously employed as a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, a Chief Medical Officer & Executive Vice President by AstraZeneca PLC, a Senior Vice President-Early Development by Genentech, Inc., and an Associate by Howard Hughes Medical Institute, Inc. He received his undergraduate degree from the University of Wisconsin and a doctorate degree from The University of California, San Francisco.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/04/2026 | 237,650 ( 0.27% ) | 2 M $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/09/2020 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Director/Board Member | 11/09/2020 |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Director/Board Member | 01/08/2019 |
| Companies | Position | End |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Director/Board Member | 17/02/2022 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 14/01/2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/07/2015 |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 01/01/2003 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Select your edition
All financial news and data tailored to specific country editions